Osteoarthritis and cardiovascular disease: a complicated relationship
https://doi.org/10.21886/2712-8156-2023-4-2-18-24
Abstract
The article presents data on the frequency of the combination of osteoarthritis and cardiovascular diseases, the features of their relationship, the possible impact of cardiovascular diseases and ongoing therapy on the development and progression of osteoarthritis.
About the Author
A. P. Rebrov
V.I. Razumovsky Saratov State Medical University
Russian Federation
Russian Federation
Andrey P. Rebrov - MD, professor, professor of hospital therapy of general medicine Department, V.I. Razumovsky Saratov State Medical University.
Saratov
References
1. Constantino de Campos G, Mundi R, Whittington C, Toutounji MJ, Ngai W, Sheehan B. Osteoarthritis, mobility-related comorbidities and mortality: an overview of meta-analyses. Ther Adv Musculoskelet Dis. 2020;12:1759720X20981219. doi: 10.1177/1759720X20981219
2. Pereira D, Peleteiro B, Araújo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage. 2011;19(11):1270-85. doi: 10.1016/j.joca.2011.08.009
3. Palmer KT, Goodson N. Ageing, musculoskeletal health and work. Best Pract Res Clin Rheumatol. 2015;29(3):391-404. doi: 10.1016/j.berh.2015.03.004
4. Louati K, Vidal C, Berenbaum F, Sellam J. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open. 2015;1(1):e000077. doi: 10.1136/rmdopen-2015-000077
5. Wang H, Bai J, He B, Hu X, Liu D. Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observational studies. Sci Rep. 2016;6:39672. doi: 10.1038/srep39672
6. Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann Rheum Dis. 2011;70(8):1354-6. doi: 10.1136/ard.2010.146399
7. Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol. 2002;1:1. doi: 10.1186/1475-2840-1-1
8. Suri P, Morgenroth DC, Hunter DJ. Epidemiology of osteoarthritis and associated comorbidities. PM R. 2012;4(5 Suppl):S10-9. doi: 10.1016/j.pmrj.2012.01.007.
9. Veronese N, Cereda E, Maggi S, Luchini C, Solmi M, Smith T, et al. Osteoarthritis and mortality: A prospective cohort study and systematic review with meta-analysis. Semin Arthritis Rheum. 2016;46(2):160-167. doi: 10.1016/j.semarthrit.2016.04.002.
10. Birtwhistle R, Morkem R, Peat G, Williamson T, Green ME, Khan S, et al. Prevalence and management of osteoarthritis in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance Network. CMAJ Open. 2015;3(3):E270-5. doi: 10.9778/cmajo.20150018
11. Marshall DA, Liu X, Barnabe C, Yee K, Faris PD, Barber C, et al. Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada. BMJ Open. 2019;9(11):e033334. doi: 10.1136/bm-jopen-2019-033334.
12. Hawker GA, Badley EM, Jaglal S. Musculoskeletal Condtitions. In: Project for an Ontario Women’s Health Evidence-Based Report. Toronto; 2010
13. Roubille C, Coste J, Sellam J, Rat AC, Guillemin F, Roux CH. Association of Baseline Cardiovascular Diseases with 5-Year Knee and Hip Osteoarthritis Progression in Non-Obese Patients: Data from the KHOALA Cohort. J Clin Med. 2021;10(15):3353. doi: 10.3390/jcm10153353.
14. Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Almasi-Hashiani A, Kaufman J, et al. Global, regional, and national burden of other musculoskeletal disorders 1990-2017: results from the Global Burden of Disease Study 2017. Rheumatology (Oxford). 2021;60(2):855-865. doi: 10.1093/rheumatology/keaa315
15. Sebbag E, Felten R, Sagez F, Sibilia J, Devilliers H, Arnaud L. The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database. Ann Rheum Dis. 2019;78(6):844-848. doi: 10.1136/annrheumdis-2019-215142
16. Omorou AY, Achit H, Wieczorek M, Pouchot J, Fautrel B, Rat AC, Guillemin F. Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohort. Qual Life Res. 2019;28(11):3047-3054. doi: 10.1007/s11136-019-02243-4
17. Nüesch E, Dieppe P, Reichenbach S, Williams S, Iff S, Jüni P. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ. 2011;342:d1165. doi: 10.1136/bmj.d1165
18. Bastick AN, Runhaar J, Belo JN, Bierma-Zeinstra SM. Prognostic factors for progression of clinical osteoarthritis of the knee: a systematic review of observational studies. Arthritis Res Ther. 2015;17(1):152. doi: 10.1186/s13075-015-0670-x
19. Yoshimura N, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage. 2012;20(11):1217-26. doi: 10.1016/j.joca.2012.06.006
20. Hall AJ, Stubbs B, Mamas MA, Myint PK, Smith TO. Association between osteoarthritis and cardiovascular disease: Systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):938-46. doi: 10.1177/2047487315610663.
21. Calders P, Van Ginckel A. Presence of comorbidities and prognosis of clinical symptoms in knee and/or hip osteoarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018;47(6):805-813. doi: 10.1016/j.semarthrit.2017.10.016.
22. Hawker GA, Croxford R, Bierman AS, Harvey PJ, Ravi B, Stanaitis I, et al. All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study. PLoS One. 2014;9(3):e91286. doi: 10.1371/journal.pone.0091286
23. Mathieu S, Couderc M, Tournadre A, Soubrier M. Cardiovascular profile in osteoarthritis: a meta-analysis of cardiovascular events and risk factors. Joint Bone Spine. 2019;86(6):679-684. doi: 10.1016/j.jbspin.2019.06.013
24. Courties A, Berenbaum F, Sellam J. The Phenotypic Approachto Osteoarthritis: A Look at Metabolic Syndrome-Associated Osteoarthritis. Joint Bone Spine. 2019;86(6):725-730. doi: 10.1016/j.jbspin.2018.12.005
25. Nishida T, Akashi S, Takigawa M, Kubota S. Effect of Angiotensin II on Chondrocyte Degeneration and Protection via Differential Usage of Angiotensin II Receptors. Int J Mol Sci. 2021;22(17):9204. doi: 10.3390/ijms22179204.
26. Thomas M, Fronk Z, Gross A, Willmore D, Arango A, Higham C, et al. Losartan attenuates progression of osteoarthritis in the synovial temporomandibular and knee joints of a chondrodysplasia mouse model through inhibition of TGF-β1 signaling pathway. Osteoarthritis Cartilage. 2019;27(4):676-686. doi: 10.1016/j.joca.2018.12.016.
27. Liu Y, Liu J, Ma Y, Zhang Y, Chen Q, Yang X, Shang Y. The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes. Bioengineered. 2022;13(1):1802-1813. doi: 10.1080/21655979.2021.1997090.
28. Nakafero G, Grainge M, Valdes A, Townsend N, Mallen C, Zhang W, et al. Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink. BMJ Open. 2019;9(8):e032050. doi: 10.1136/bmjo-pen-2019-032050.
29. Nakafero G, Grainge MJ, Valdes AM, Townsend N, D Mallen C, Zhang W, et al. β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score-matched cohort study. Rheumatology (Oxford). 2021;60(12):5686-5696. doi: 10.1093/rheumatology/keab234
30. Perry TA, Wang X, Nevitt M, Abdelshaheed C, Arden N, Hunter DJ. Association between current medication use and progression of radiographic knee osteoarthritis: data from the osteoarthritis initiative. Rheumatology (Oxford). 2021;60(10):4624-4632. doi: 10.1093/rheumatology/keab059.
31. Wang J, Dong J, Yang J, Wang Y, Liu J. Association between statin use and incidence or progression of osteoarthritis: meta-analysis of observational studies. Osteoarthritis Cartilage. 2020;28(9):1170-1179. doi: 10.1016/j.joca.2020.04.007.
32. Eymard F, Parsons C, Edwards MH, Petit-Dop F, Reginster JY, Bruyère O, et al. Statin use and knee osteoarthritis progression: Results from a post-hoc analysis of the SEKOIA trial. Joint Bone Spine. 2018;85(5):609-614. doi: 10.1016/j.jbspin.2017.09.014
Review
For citations:
Rebrov A.P. Osteoarthritis and cardiovascular disease: a complicated relationship. South Russian Journal of Therapeutic Practice. 2023;4(2):18-24. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-2-18-24
Views:
1417
Email this article 